Pesquisa

Edição
Título
Autores
Nº 3 (2024)
Efficacy and safety of the polypeptide drug «Vesusten» in the correction of neurogenic LUTS in multiple sclerosis. Results of the pilot study
Abdallah N., Belousov I., Kogan M., Goncharova Z., Belousova M.
PDF
(Rus)
Nº 2 (2023)
The results of the multicenter prospective comparative study of Fndrogel in men with endogenous testosterone deficiency and lower urinary tract symptoms, associated with benign prostate hyperplasia («Potok»)
Kogan M., Avadieva N., Gevorkyan L., Loginov Y., Metelkin A., Mitin A., Patrikeev A.
PDF
(Rus)
Nº 1 (2024)
Practical use of Adenoprosin® in combination therapy in men with lower urinary tract symptoms
Kasyan G., Khodyreva L., Grigoryan B., Dyakov V.
PDF
(Rus)
Nº 1 (2018)
COMPLICATIONS OF THE HOLMIUM LASER ENUCLEATION OF PROSTATE FOR BENIGN PROSTATIC HYPERPLASIA
Davydov D., Tsarichenko D., Bezrukov E., Sukhanov R., Vinarov A., Sorokin N., Enikeev D., Dymov A., Danilov S.
PDF
(Rus)
Nº 1 (2019)
«LUTS/BPH - who treats?». The results of the epidemiologic study
Pushkar D., Rasner P., Aboyan I., Asfandiyarov F., Kotov S., Kogan M., Korneev I., Medvedev V., Neymark A., Novikov A., Pavlov V., Tsukanov A., Shabalkin S., Shormanov I.
PDF
(Rus)
Nº 5 (2022)
Evolution of views on the etiology and pathogenesis of lower urinary tract symptoms for men
Tyuzikov I., Tishova Y.
PDF
(Rus)
Nº 2 (2022)
Therapeutic efficacy and safety of monotherapy Alfuprost® MR 10 mg/day in clinical practice
Novikov A., Shpilenya E.
PDF
(Rus)
Nº 3 (2018)
En bloc holmium laser enucleation of the prostate (HOLEP EN BLOC): our experience
Rapoport L., Sorokin N., Sukhanov R., Dymov A., Enikeev D., Davydov D., Danilov S.
PDF
(Rus)
Nº 6 (2022)
Molecular genetic predictors of the efficacy and safety of tamsulosin therapy
Abdullaev S., Shatokhin M., Teodorovich O., Sychev D.
PDF
(Rus)
Nº 1 (2022)
Management of lower urinary tract symptoms in patients with benign prostatic hyperplasia during COVID-19. results of an all-russian observational study “ATLANT”
Neymark B., Neymark A., Yakovets Y., Nozdrachev N., Ibishev K., Kuzmin I.
PDF
(Rus)
Nº 3 (2018)
Specific features of lower urinary tract symptoms in men living in the moscow region. Results of the epidemiological study
Pushkar D., Rasner P., Kotenko D., Gerasimov A., Shabalkin S.
PDF
(Rus)
Nº 6 (2022)
The influence of alfuzosin monotherapy on the sexual function of patients with benign prostatic hyperplasia in real clinical practice (results of a Russian multicenter study)
Pushkar D., Loran O., Bernikov A.
PDF
(Rus)
Nº 6 (2021)
Outpatient urodynamic monitoring in patients with BPH: world and russian experience
Shaderkin I., Lebedev G., Shaderkina V., Monakov D., Spivak L., Gadzhieva Z., Gazimiev M.
PDF
(Rus)
Nº 2 (2018)
The effectiveness and safety of Omnik OCAS in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia in the routine clinical practice in the Russian Federation (prospective multi-center observing program)
Loran O., Seregin A.
PDF
(Rus)
Nº 6 (2021)
Modern possibilities of therapy of a urological patient with concomitant diseases of the cardiovascular system
Kuzmenko A., Kuzmenko V., Gyaurgiev T.
PDF
(Rus)
Nº 3 (2014)
EXPERIENCE OF THE USE OF DRUG UROREC: EFFICACY AND SAFETY
Kadiev R., Derevyanko T.
PDF
(Rus)
Nº 5 (2021)
Lower urinary tract symptoms and COVID-19
Bernikov A., Kupriyanov A., Stroganov R., Arefieva O., Khodyreva L., Zaitsev A.
PDF
(Rus)
Nº 3 (2014)
DETERMINANTS OF RISK OF THE DEVELOPMENT OF ERECTILE DYSFUNCTION IN THE RUSSIAN FEDERATION: ANALYSIS OF EPIDEMIOLOGICAL STUDIES
Korneev I., Alekseeva T., Al-Shukri S., Bernikov A., Erkovich A., Zhuravlev V., Kamalov A., Kogan M., Pavlov V., Pushkar D.
PDF
(Rus)
Nº 2 (2021)
NEW APPROACHES TO COMBINED THERAPY OF IRRITATIVE SYMPTOMS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
Ergakov D., Martov A.
PDF
(Rus)
Nº 5 (2012)
SILODOSIN THERAPY FOR LOWER URINARY TRACT SYMPTOMS IN MEN WITH SUSPECTED BENIGN PROSTATIC HYPERPLASIA: RESULTS OF AN INTERNATIONAL, RANDOMIZED, DOUBLE-BLIND, PLACEBOAND ACTIVE-CONTROLLED CLINICAL TRIAL PERFORMED IN EUROPE
Chapple C., Montorsi F., Tammela T., Wirth M., Koldewijn E., Fernandez F.
PDF
(Rus)
Nº 3 (2019)
The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-naive patients with benign prostatic hyperplasia
Kupriyanov Y., Rasner P., Rokhlikov I., Akrikidi A., Soloviev V., Markov A., Nozdrin E., Logvinov L., Vasilevskiy R., Skrupskiy K., Pushkar D., Putilovskiy M., Epstein O.
PDF
(Rus)
Nº 3 (2022)
CURRENT ISSUES IN ALPHA1-ADRENERGIC BLOCKER THERAPY: INTEGRATION OF PHARMACOLOGICAL APPROACH AND CLINICAL EXPERIENCE
Martov A., Dukhanin A., Bernikov A.
PDF
(Rus)
1 - 22 de 22 resultados
Dicas:
  • Palavras-chave são sensíveis a maiúsculas
  • Preposições e conjunções ingleses são ignoradas
  • Busca é feita por todos os palavras-chave (agente AND experimentador) por omissão
  • Use OR para pesquisar um termo exato, ex.: educação OR formação
  • Use parênteses para criar frases complexas, ex.: arquivo de ((revistas OR conferências) NOT teses)
  • Para pesquisar uma frase precisa use aspas duplas, ex.: "investigações científicas"
  • Exclua uma palavra utilizando o sinal - (hífen) ou operador NOT; ex.: concurso-de beleza ou concurso NOT de beleza
  • Use * como caractere-coringa, ex.: científic* recuperará as palavras "científico", "científicos", etc.

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies